Stock Events

Stock Events

Inhibikase Therapeutics (IKT) Q2 2025 Earnings

14MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.67

-0.15

0.36

0.88

Details

Expected EPS

-0.1

Actual EPS

-0.15

Surprise EPS

-0.05

Surprise Percent

+50%

Description

Inhibikase Therapeutics (IKT) has reported earnings of -0.15 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.